SCHEMBL18274473

SCHEMBL18274473

N#CC(c1ccc(Cl)cc1F)N1CCOCC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.61
SMN1; SMN2 Q16637 3/20 0.47
ACHE P22303 2/20 0.45
MAPT P10636 2/20 0.44
HTT P42858 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
KDM4E B2RXH2 1/20 0.41
HSD17B10 Q99714 1/20 0.41
SLC6A2 P23975 1/20 0.39
LMNA P02545 2/20 0.39
GAA P10253 1/20 0.36
FPR2 P25090 1/20 0.36
PROKR1 Q8TCW9 1/20 0.36
P4HB P07237 1/20 0.36
SMAD3 P84022 1/20 0.36
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36
CYP2A13 Q16696 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18274467 0.86 ALDH1A1 (0.64) ALDH1A1SMN1; SMN2ACHEMAPTHTT
SCHEMBL2782859 0.86 SLC6A2 (0.52) ALDH1A1SMN1; SMN2ACHEMAPTHTT
SCHEMBL2779689 0.80 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2ACHEMAPTHTT
SCHEMBL2783237 0.78 ALDH1A1 (0.69) ALDH1A1SMN1; SMN2ACHEL3MBTL1MEN1
SCHEMBL1019672 0.76 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2ACHEMAPTHTT
SCHEMBL18274501 0.75 ALDH1A1 (0.66) ALDH1A1SMN1; SMN2ACHEL3MBTL1MEN1
SCHEMBL15797534 0.75 DPP4 (0.59) ALDH1A1MAPTHTTSLC6A2LMNA
SCHEMBL11154769 0.74 ALDH1A1 (0.68) ALDH1A1SMN1; SMN2ACHEMAPTHTT
SCHEMBL2781199 0.74 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2ACHEMAPTHTT
SCHEMBL15797532 0.73 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2MAPTHTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2931717-B1 INDOLE CARBOXAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2016-12-07 EP disclosed